Advertisement

Poorly Differentiated Thyroid Carcinoma

  • Lori A. Erickson
Chapter
Part of the Atlas of Anatomic Pathology book series (AAP)

Abstract

Poorly differentiated thyroid carcinomas are diagnostically controversial, as there is a lack of consensus regarding diagnostic criteria. Poorly differentiated thyroid carcinomas usually occur in older patients (>50 years) and are more common in Italy and Latin America (4–7 % of thyroid carcinomas) and less common in the United States. These tumors are morphologically and prognostically intermediate between well-differentiated and anaplastic thyroid carcinoma. An operational pathologic definition offered in 2007 included insular and trabecular variants, but not solid lesions or more differentiated tumors that may have a poor prognosis, such as tall cell, columnar, diffuse sclerosing, and oncocytic lesions. At a consensus conference in Turin in 2006, 12 thyroid pathologists evaluated 83 tumors without knowledge of clinical parameters and devised a diagnostic algorithm for the diagnosis of poorly differentiated thyroid carcinoma to include “(1) presence of a solid/trabecular/insular pattern of growth, (2) absence of the conventional nuclear features of papillary carcinoma, and (3) presence of at least one of the following features: convoluted nuclei; mitotic activity ≥3×10 HPF [high-power fields]; and tumor necrosis.”

References

  1. 1.
    Tallini G. Poorly differentiated thyroid carcinoma. Are we there yet? Endocr Pathol. 2011;22(4):190–4.PubMedCrossRefGoogle Scholar
  2. 2.
    Sanders Jr EM, et al. An evidence-based review of poorly differentiated thyroid cancer. World J Surg. 2007;31(5):934–45.PubMedCrossRefGoogle Scholar
  3. 3.
    Volante M, Papotti M. Poorly differentiated thyroid carcinoma: 5 years after the 2004 WHO classification of endocrine tumours. Endocr Pathol. 2010;21(1):1–6.PubMedCrossRefGoogle Scholar
  4. 4.
    DeLellis RA, Lloyd RV, Heitz PU. WHO classification of tumours—pathology and genetics. In: DeLellis RA, Lloyd RV, Heitz PU, editors. Tumours of endocrine organs. Lyon: IARC Press; 2004.Google Scholar
  5. 5.
    Volante M, et al. Poorly differentiated thyroid carcinoma: the Turin proposal for the use of uniform diagnostic criteria and an algorithmic diagnostic approach. Am J Surg Pathol. 2007;31(8):1256–64.PubMedCrossRefGoogle Scholar
  6. 6.
    Asioli S, et al. Poorly differentiated carcinoma of the thyroid: validation of the Turin proposal and analysis of IMP3 expression. Mod Pathol. 2010;23(9):1269–78.PubMedCrossRefGoogle Scholar
  7. 7.
    Tanaka K, et al. Analysis of clinical outcome of patients with poorly differentiated thyroid carcinoma. ISRN Endocrinol. 2011;2011:308029.PubMedCentralPubMedGoogle Scholar
  8. 8.
    Ibrahimpasic T, et al. Poorly differentiated thyroid carcinoma presenting with gross extrathyroidal extension: 1986–2009 Memorial Sloan-Kettering Cancer Center experience. Thyroid. 2013;23(8):997–1002.PubMedCrossRefGoogle Scholar
  9. 9.
    Papotti M, et al. Poorly differentiated thyroid carcinomas with primordial cell component. A group of aggressive lesions sharing insular, trabecular, and solid patterns. Am J Surg Pathol. 1993;17(3):291–301.PubMedCrossRefGoogle Scholar
  10. 10.
    Volante M, et al. Poorly differentiated carcinomas of the thyroid with trabecular, insular, and solid patterns: a clinicopathologic study of 183 patients. Cancer. 2004;100(5):950–7.PubMedCrossRefGoogle Scholar
  11. 11.
    Nikiforov YE. Genetic alterations involved in the transition from well-differentiated to poorly differentiated and anaplastic thyroid carcinomas. Endocr Pathol. 2004;15(4):319–27.PubMedCrossRefGoogle Scholar
  12. 12.
    Albores-Saavedra J, Carrick K. Where to set the threshold between well differentiated and poorly differentiated follicular carcinomas of the thyroid. Endocr Pathol. 2004;15(4):297–305.PubMedCrossRefGoogle Scholar
  13. 13.
    Volante M, et al. RAS mutations are the predominant molecular alteration in poorly differentiated thyroid carcinomas and bear prognostic impact. J Clin Endocrinol Metab. 2009;94(12):4735–41.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • Lori A. Erickson
    • 1
  1. 1.Mayo Clinic College of MedicineRochesterUSA

Personalised recommendations